Drug details

Cutaquig (immune globulin intravenous, human)

type of Immune Globulins

Cutaquig (immune globulin subcutaneous (human) - hipp) is a 16.5% immune globulin solution for subcutaneous infusion indicated for treatment of primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. This includes, but is not limited to, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

This drug may have the following side effects:

• shortness of breath,
• lightheadedness,
• dizziness,
• weakness,
• fever,
• swelling,
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• wheezing, 
• confusion, 
• rapid weight gain, 
• rapid heart rate, 
• eye pain, 
• dark colored urine, 
• numbness or weakness on one side of the body, and
• swelling and warmth or discoloration in an arm or leg
• chest tightness, 
• pale or yellowed skin, 
• little or no urination, 
• chest pain with or without deep breathing,
• blue colored lips, fingers, or toes, 
• fever with a severe headache, 
• neck stiffness, 
• increased sensitivity to light, 

The following drugs are related to Cutaquig, either as a replacement or used together:

• Bivigam (immune globulin intravenous (human), 10%)
• Cuvitru (immune globulin subcutaneous (human), 20% solution)
• Hizentra (immune globulin subcutaneous (human) injection)
• Xembify (immune globulin subcutaneous, human – klhw injection)